Validity of MRI measures as surrogate markers in clinical trials of beta-interferon in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Tremlett, H
Traboulsee, A
Li, D
Paty, D
机构：
来源：
NEUROLOGY | 2004年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A292 / A293
页数：2
相关论文
共 50 条
  • [21] The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
    Madsen, Claus
    [J]. BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [22] Beta-interferon clinical trials using MRI in patients with multiple sclerosis.
    Lebrun, C
    [J]. REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 761 - 767
  • [23] Immunomonitoring measures in relapsing-remitting multiple sclerosis
    Matsui, M
    Araya, S
    Wang, HY
    Matsushima, K
    Saida, T
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 148 (1-2) : 192 - 199
  • [24] Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
    Lavery, Amy M.
    Verhey, Leonard H.
    Waldman, Amy T.
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2014, 2014
  • [25] Response to interferon beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 64 - 65
  • [26] Heavy neurofilament phosphoforms in relapsing-remitting multiple sclerosis: correlation with MRI measures and clinical disability
    Annunziata, P.
    Cioni, C.
    De Santi, L.
    Stromillo, M. L.
    Di Perri, C.
    Federico, A.
    De Stefano, N.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 26 - 26
  • [27] Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
    Sorensen, PS
    Ross, C
    Clemmesen, KM
    Bendtzen, K
    Frederiksen, JL
    Jensen, K
    Kristensen, O
    Petersen, T
    Rasmussen, S
    Ravnborg, M
    Stenager, E
    Koch-Henriksen, N
    [J]. LANCET, 2003, 362 (9391): : 1184 - 1191
  • [28] Disability trends and outcome measures in treatment trials of relapsing-remitting multiple sclerosis
    Blumhardt, L
    Liu, C
    [J]. ANNALS OF NEUROLOGY, 1999, 46 (03) : 502 - 502
  • [29] In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim
    Fianne L. P. Sips
    Francesco Pappalardo
    Giulia Russo
    Roberta Bursi
    [J]. BMC Medical Informatics and Decision Making, 22
  • [30] In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim
    Sips, Fianne L. P.
    Pappalardo, Francesco
    Russo, Giulia
    Bursi, Roberta
    [J]. BMC MEDICAL INFORMATICS AND DECISION MAKING, 2022, 22 (SUPPL 6)
12345